FDA Communications Key To Court Dismissal Of Diabetes Product Liability Suits
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck, AstraZeneca and Novo Nordisk's incretin mimetics win as district judge cites FDA’s history of rejecting pancreatic cancer warnings.